Skip to main content

Pamela Susan Douglas CV

Ursula Geller Distinguished Professor of Research in Cardiovascular Diseases
Medicine, Cardiology
Duke Box 17969, Durham, NC 27705
300 W. Morgan St Room 841, Durham, NC 27701
CV

Selected Grants


Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease

ResearchCo Investigator · Awarded by NYU Langone Medical Center · 2023 - 2028

Pericoronary adipose tissue density a novel CT-derived marker of local inflammation and coronary artery disease in patients living with HIV

ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2023 - 2027

REPRIEVE Extension for Trial Completion

ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2024 - 2026

Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2022 - 2025

Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease

ResearchCo Investigator · Awarded by NYU Langone Medical Center · 2023 - 2028

Pericoronary adipose tissue density a novel CT-derived marker of local inflammation and coronary artery disease in patients living with HIV

ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2023 - 2027

REPRIEVE Extension for Trial Completion

ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2024 - 2026

Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2022 - 2025

Postdoctoral Training in Cardiovascular Clinical Research

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2025

PRECISE

Clinical TrialPrincipal Investigator · Awarded by HeartFlow, Inc. · 2018 - 2024

Clinical and Molecular Epidemiology of High Risk Coronary Plaque

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2024

Inflammatory and Metabolic Biomarkers in Cardiovascular Complications with SARS-CoV-2

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2024

Abbott Diagnostics Collaborative Sponsored Research Agreement

ResearchCo Investigator · Awarded by Abbott Laboratories · 2016 - 2022

Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2014 - 2021

The Aga Khan University-Pakistan Initiative for NCDs (AKUPI-NCDs)

ResearchCo Investigator · Awarded by Aga Khan University · 2019 - 2020

PAH_POC

Clinical TrialPrincipal Investigator · Awarded by Akros Medical · 2017 - 2020

Cardiovascular Disease Risk in HIV-infected Women: Sex-Specific Mechanisms of Risk and Risk Reduction among REPRIEVE Trial Participants

ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2015 - 2019

Aerobic Training During or After Adjuvant Therapy: A Randomized Trial

Clinical TrialPrincipal Investigator · Awarded by Memorial Sloan-Kettering Cancer Center · 2014 - 2019

Reducing Risk of Anthracycline-related Heart Failure after Childhood Cancer

ResearchPrincipal Investigator · Awarded by City of Hope · 2015 - 2019

MITRAL Trial

Clinical TrialPrincipal Investigator · Awarded by North Shore University Hospital · 2015 - 2018

PROMISE Substudy to Assess For Effective dose of Radiation (PROMISE-SAFER)

ResearchPrincipal Investigator · Awarded by Columbia University · 2011 - 2018

PROMISE Trial: Clinical Coordinating Center

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2016

SCUSF 0806 Phase II placebo--controlled trial of lisinopril and Coreg

ResearchPrincipal Investigator · Awarded by University of South Florida · 2016 - 2016

SCUSF 0806 Phase II placebo--controlled trial of lisinopril and Coreg

ResearchPrincipal Investigator · Awarded by University of South Florida · 2013 - 2014

Cardiovascular Cell Therapy Research Network (CCTRN) / CELLVAD-ADRC Protocol

Clinical TrialPrincipal Investigator · Awarded by University of Texas Health Science Center at Houston · 2014 - 2014

Aerobic Training During or After Adjuvant Therapy: A Randomized Trial

ResearchCo Investigator · Awarded by National Institutes of Health · 2012 - 2014

Phase III Trial of Exercise Training in Postsurgical Lung Cancer

ResearchInvestigator · Awarded by National Institutes of Health · 2009 - 2014

Standardized Collection and Submission of Cardiovascular Endpoint Data

ResearchCollaborator · Awarded by Food and Drug Administration · 2012 - 2013

Data Concepts and Terminology Standards in Cardiovascular Imaging (R24)

ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2012 - 2013

Synthesis and Harmonization of High Impact Data Elements

ResearchCo Investigator · Awarded by Food and Drug Administration · 2011 - 2013

Multi-Scale Model of the Human Heart for Imaging Research

ResearchCollaborator · Awarded by National Institutes of Health · 2009 - 2013

Exercise Training, Erectile Dysfunction, and Prostate Cancer

ResearchConsultant · Awarded by National Institutes of Health · 2009 - 2013

Assessment of Outcomes and Bleeding Complications Following Implantation of DES and DAPT

ResearchCo Investigator · Awarded by Food and Drug Administration · 2010 - 2013

DEcIDE DES TO4 W3

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2009 - 2012

DEcIDE Stents TO4 WA2

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2009 - 2012

DEcIDE AVR

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2009 - 2011

Collaborative Research on the Clinical Effectiveness and Long-term Outcomes of Stents in Coronary Interventions

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2008 - 2009

External Relationships


  • Caption Health
  • Foresite Labs
  • Wolters Kluwer Health (publishing)

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.